Cardax Pharmaceuticals

2800 Woodlawn Drive, Suite 129
Honolulu, Hawaii 96822 USA
Click for website

Research Sector Pharmaceuticals

Summary Description Nutraceuticals and pharmaceuticals to combat inflammatory disease

Management David G. Watumull, President and CEO; Gilbert M. Rishton, CSO; Timothy J. King, VP Research; David M. Watumull, VP Operations

Click here for Financial Data
Keywords: Inflammation, osteoarthritis, arthritis, cardiovascular disease, triglycerides, dyslipidemia, metabolic disease, hepatitis, astaxanthin, zeaxanthin, biotechnology, pharmaceuticals


Updated: Oct. 23, 2015


Developing nutraceuticals and pharmaceuticals that combine the anti-inflammatory benefits of steroids or NSAIDS with GRAS ("Generally Recognized as Safe") safety status, the FDA's ultimate safety desi......view more

Products / Services

CDX-085/Heptax/Xancor (lead compound) - pro-drug of antioxidant carotenoid astanxanthin; in pre-clinical development as pharmaceutical for metabolic syndrome, rheumatoid arthritis and re-thrombosis.......view more

Technology / Differentiation

Development stage life sciences, focused on anti-inflammatory nutraceuticals and pharmaceuticals Platform: proprietary synthetic derivatives of astaxanthin, claimed to have higher purity and bioava...view more

Market / Customers

Osteoarthritis, RA, Triglyceride Reduction, Diabetes, Cognitive Decline, Liver Disease Only natural astaxanthin currently approved with human uses market estimated at $27-40MM. Growth is expected a......view more

Competitors / Substitutes / Alternatives

Major players in astaxanthin are not developing as pharmaceutical. Parry Nutraceuticals/Valensa (India)/Nutraceutical: Natural astaxanthin Algae Technologies (Israel)/Nutraceutical: ASTApure Cyan...view more